ArticleDrug design, development and therapy2021

A Retrospective Cohort Study Evaluates Clinical Value of Anlotinib in Persistent, Metastatic, or Recurrent Cervical Cancer After Failure of First-Line Therapy.

Hui Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.